Literature DB >> 22801663

[Treatment of brain tumor patients: hyperthermia, hyperbaric oxygenation, electric fields or nanoparticles].

M Platten1, W Wick.   

Abstract

Despite considerable advancements in the therapy of malignant glioma in recent years with modern radiation and surgical techniques, alkylating and antiangiogenic chemotherapy, as well as molecular-based treatment decisions, treatment outcomes are mostly unsatisfactory. Understandably, patients often ask for experimental, sometimes unusual therapeutic modalities and this should be integrated into the clinical practice. In addition to experimental therapeutic approaches based on novel drugs, viral agents, immunotherapy and radiation approaches, experimental procedures of interest for patients particularly encompass mechanical approaches with the aim at physically altering the tumor tissue by temperature, oxygenation or magnetization. These mechanical procedures are based on intuitive concepts and promise fewer side effects than other experimental approaches. In addition, the requirements for approval by medical device regulations in terms of proof of efficacy are generally less stringent. As a consequence approaches, such as hyperbaric oxygenation, hyperthermia and electric fields, which are often heavily advertised and in part reimbursed by health insurances, have been used for many years, often by centers not specialized in the treatment of brain tumor patients, although sound data from prospective controlled clinical trials that determine which patients in which situation may benefit, are generally lacking. In this review we review these clinical therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22801663     DOI: 10.1007/s00115-012-3569-7

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  22 in total

1.  A phase II clinical study on relapsed malignant gliomas treated with electro-hyperthermia.

Authors:  Giammaria Fiorentini; Petros Giovanis; Susanna Rossi; Patrizia Dentico; Raffaele Paola; Gina Turrisi; Paolo Bernardeschi
Journal:  In Vivo       Date:  2006 Nov-Dec       Impact factor: 2.155

2.  Sensitization to CD95 ligand-induced apoptosis in human glioma cells by hyperthermia involves enhanced cytochrome c release.

Authors:  M Hermisson; B Wagenknecht; H Wolburg; T Glaser; J Dichgans; M Weller
Journal:  Oncogene       Date:  2000-05-04       Impact factor: 9.867

3.  Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: results of a feasibility study on patients with glioblastoma multiforme.

Authors:  Klaus Maier-Hauff; Ronny Rothe; Regina Scholz; Uwe Gneveckow; Peter Wust; Burghard Thiesen; Annelie Feussner; Andreas von Deimling; Norbert Waldoefner; Roland Felix; Andreas Jordan
Journal:  J Neurooncol       Date:  2006-06-14       Impact factor: 4.130

4.  Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group.

Authors:  J van der Zee; D González González; G C van Rhoon; J D van Dijk; W L van Putten; A A Hart
Journal:  Lancet       Date:  2000-04-01       Impact factor: 79.321

5.  Phase II trial of radiotherapy after hyperbaric oxygenation with multiagent chemotherapy (procarbazine, nimustine, and vincristine) for high-grade gliomas: long-term results.

Authors:  Kazuhiko Ogawa; Shogo Ishiuchi; Osamu Inoue; Yoshihiko Yoshii; Atsushi Saito; Takashi Watanabe; Shiro Iraha; Takafumi Toita; Yasumasa Kakinohana; Takuro Ariga; Goro Kasuya; Sadayuki Murayama
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-03-21       Impact factor: 7.038

6.  Disruption of cancer cell replication by alternating electric fields.

Authors:  Eilon D Kirson; Zoya Gurvich; Rosa Schneiderman; Erez Dekel; Aviran Itzhaki; Yoram Wasserman; Rachel Schatzberger; Yoram Palti
Journal:  Cancer Res       Date:  2004-05-01       Impact factor: 12.701

Review 7.  Radiotherapy and radiosensitizers in the treatment of glioblastoma multiforme.

Authors:  Julie E Chang; Deepak Khuntia; H Ian Robins; Minesh P Mehta
Journal:  Clin Adv Hematol Oncol       Date:  2007-11

8.  Pharmacokinetic investigation of increased efficacy against malignant gliomas of carboplatin combined with hyperbaric oxygenation.

Authors:  Yu Suzuki; Katsuyuki Tanaka; Daisuke Negishi; Makiko Shimizu; Yasuyuki Yoshida; Takuo Hashimoto; Hiroshi Yamazaki
Journal:  Neurol Med Chir (Tokyo)       Date:  2009-05       Impact factor: 1.742

9.  Fractionated stereotactic radiotherapy using gamma unit after hyperbaric oxygenation on recurrent high-grade gliomas.

Authors:  Kiyotaka Kohshi; Haruaki Yamamoto; Ai Nakahara; Takahiko Katoh; Masashi Takagi
Journal:  J Neurooncol       Date:  2006-11-22       Impact factor: 4.506

10.  Phase II trial of radiotherapy after hyperbaric oxygenation with chemotherapy for high-grade gliomas.

Authors:  K Ogawa; Y Yoshii; O Inoue; T Toita; A Saito; Y Kakinohana; G Adachi; S Iraha; W Tamaki; K Sugimoto; A Hyodo; S Murayama
Journal:  Br J Cancer       Date:  2006-09-05       Impact factor: 7.640

View more
  1 in total

1.  Hyperbaric Oxygen Therapy as a Complementary Treatment in Glioblastoma-A Scoping Review.

Authors:  Diogo Alpuim Costa; Mafalda Sampaio-Alves; Eduardo Netto; Gonçalo Fernandez; Edson Oliveira; Andreia Teixeira; Pedro Modas Daniel; Guilherme Silva Bernardo; Carla Amaro
Journal:  Front Neurol       Date:  2022-07-01       Impact factor: 4.086

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.